https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-01-01 / Int. J. Radiat. Oncol. Biol. Phys. 2000 Jan;46(1):179-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-01-01 / Int. J. Radiat. Oncol. Biol. Phys. 2000 Jan;46(1):179-852000-01-01 00:00:002000-01-01 00:00:00Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1998-06-01 / J Surg Oncol 1998 Jun;68(2):79-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1998-06-01 / J Surg Oncol 1998 Jun;68(2):79-911998-06-01 00:00:002019-02-15 08:53:20Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1997-07-01 / Anticancer Res. 1997 Jul-Aug;17(4B):2899-902
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1997-07-01 / Anticancer Res. 1997 Jul-Aug;17(4B):2899-9021997-07-01 00:00:001997-07-01 00:00:00Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1994-12-01 / Cancer Res. 1994 Dec;54(23):6017-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1994-12-01 / Cancer Res. 1994 Dec;54(23):6017-211994-12-01 00:00:001994-12-01 00:00:00Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1984-06-15 / Cancer 1984 Jun;53(12):2585-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1984-06-15 / Cancer 1984 Jun;53(12):2585-911984-06-15 00:00:001984-06-15 00:00:00Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma
